Marquette Asset Management, LLC - TSCAN THERAPEUTICS INC ownership

TSCAN THERAPEUTICS INC's ticker is and the CUSIP is 89854M101. A total of 30 filers reported holding TSCAN THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
Marquette Asset Management, LLC ownership history of TSCAN THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$88,000
-3.3%
28,8950.0%0.03%
+7.7%
Q2 2022$91,000
+12.3%
28,8950.0%0.03%
+36.8%
Q1 2022$81,000
-16.5%
28,895
+33.7%
0.02%
-5.0%
Q4 2021$97,00021,6180.02%
Other shareholders
TSCAN THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
DC Funds, LP 630,000$2,835,00016.79%
DC Investments Management, LLC 35,563$160,0000.23%
Deer Management Co. LLC 1,245,505$5,605,0000.14%
Alphabet Inc. 1,077,080$4,847,0000.12%
RA Capital Management 1,255,317$5,649,0000.10%
HHLR ADVISORS, LTD. 1,282,976$5,773,0000.09%
Nan Fung Group Holdings Ltd 48,600$219,0000.06%
Baker Brothers Advisors 1,425,000$6,413,0000.03%
Tekla Capital Management LLC 200,000$900,0000.03%
Marquette Asset Management, LLC 21,618$97,0000.02%
View complete list of TSCAN THERAPEUTICS INC shareholders